Analysis of altered proteins related to blast crisis in chronic myeloid leukemia by proteomic study

International Journal of Laboratory Hematology

Volumn 34, Issue 3, 2012, Pages 267-273

  Zhang, J ^a   Jin, Z ^a   Du, Q ^a   Li, R ^a   Yao, F ^a   Huang, B ^a   Xu, N ^a   Xu, L ^a   Luo, X ^a   Liu, X ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

Author keywords

Blast crisis; Chronic myeloid leukemia; Proteomics

Indexed keywords

BIOLOGICAL MARKER; DJ 1 PROTEIN; ENOLASE; ENOLASE 2; GUANINE NUCLEOTIDE BINDING PROTEIN; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN K; LEUKOTRIENE A4 HYDROLASE; LIPOCORTIN 1; LIPOCORTIN 4; PROTEASOME; PROTEASOME ACTIVATOR COMPLEX; PROTEASOME SUBUNIT 4BETA; PROTEASOME SUBUNIT 6ALPHA; PROTEIN; PROTEINASE; RAC PROTEIN; RAC RHO DISSOCIATION INHIBITOR; RHO FACTOR; RHO GDP DISSOCIATION INHIBITOR; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; THIOREDOXIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BLAST CELL CRISIS; BONE MARROW CELL; CANCER PATIENT; CHRONIC MYELOID LEUKEMIA; CHRONICITY; CLINICAL ARTICLE; CONTROLLED STUDY; DATA ANALYSIS SOFTWARE; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; FLUORESCENCE IN SITU HYBRIDIZATION; GENE EXPRESSION PROFILING; HISTOPATHOLOGY; HUMAN; HUMAN CELL; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROGNOSIS; PROTEIN ANALYSIS; PROTEIN DEGRADATION; PROTEOMICS; SIGNAL TRANSDUCTION; TWO DIMENSIONAL GEL ELECTROPHORESIS; WESTERN BLOTTING;

ADULT; AGED; ANNEXINS; BLAST CRISIS; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; FEMALE; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LEUKEMIA, MYELOID, CHRONIC-PHASE; MALE; MIDDLE AGED; MONOCYTES; NEOPLASM PROTEINS; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEOMICS; RHOA GTP-BINDING PROTEIN; RIBONUCLEOPROTEINS; YOUNG ADULT;

EID: 84860242022     PISSN: 17515521     EISSN: 1751553X     Source Type: Journal    
DOI: 10.1111/j.1751-553X.2011.01389.x     Document Type: Article

References (16)

1. An X., Tiwari A.K., Sun Y., Ding P.R., Ashby Jr C.R. & Chen Z.S. (2010) BCR-ABL tyrosine kinase inhibitors in the treatment of Philadelphia chromosome positive chronic myeloid leukemia: a review. Leukemia Research 34, 1255-1268.
2. Chen X., Wang S., Wu N. & Yang C.S. (2004) Leukotriene A4 hydrolase as a target for cancer prevention and therapy. Current cancer drug targets 4, 267-283.
3. Du Q., Wang L., Zhu H., Zhang S., Xu L., Zheng W. & Liu X. (2010) The role of heterogeneous nuclear ribonucleoprotein K in the progression of chronic myeloid leukemia. Medical Oncology 27, 673-679.
4. Hu Z., Pan X.F. & Wu F.Q. (2009) Synergy between Proteasome Inhibitors and IM Mesylate in Chronic Myeloid Leukemia. PLoS One 4, e6257.
5. Jabbour E., Cortes J. & Kantarjian H. (2010) Long-term outcomes in the second-line treatment of chronic myeloid leukemia: a review of tyrosine kinase inhibitors. Cancer 117, 897-906.
6. Kasprzak A., Zabel M. & Biczysko W. (2007) Selected markers (chromogranin A, neuron-specific enolase, synaptophysin, protein gene product 9.5) in diagnosis and prognosis of neuroendocrine pulmonary tumours. Polish Journal of Pathology 58, 23-33.
7. Kuzelová K. & Hrkal Z. (2008) Rho-signaling pathways in chronic myelogenous leukemia. Cardiovasc Hematol Disord Drug Targets 8, 261-267.
8. Liu H., Wang M., Li M., Wang D., Rao Q., Wang Y., Xu Z. & Wang J (2008) Expression and role of DJ-1 in leukemia. Biochemical and biophysical research communications 375, 477-483.
9. Moumen A., Masterson P., O'Connor M.J. & Jackson S.P. (2005) HnRNP K: an HDM2 target and transcriptional coactivator of p53 in response to DNA damage. Cell 123, 1065-1078.
10. Notari M., Neviani P., Santhanam R., Blaser B.W., Chang J.S., Galietta A., Willis A.E., Roy D.C., Caligiuri M.A., Marcucci G. & Perrotti D. (2006) A MAPK/HNRPK pathway controls BCR/ABL oncogenic potential by regulating MYC mRNA translation. Blood 107, 2507-2516.
11. Sheng J. & Zhang W.Y. (2010) Identification of biomarkers for cervical cancer in peripheral blood lymphocytes by oligonucleotide microarrays. Chinese Medical Journal 123, 1000-1005.
12. Sokal J.E., Cox E.B., Baccarani M., Tura S., Gomez G.A., Robertson J.E., Tso C.Y., Braun T.J., Clarkson B.D. & Cervantes F. (1984) Prognostic discrimination in "good-risk" chronic granulocytic leukemia. Blood 63, 789-799.
13. Steelman L.S., Pohnert S.C., Shelton J.G., Franklin R.A., Bertrand F.E. & McCubrey J.A. (2004) JAK/STAT, Raf/MEK/ERK, PI3K/Akt and BCR-ABL in cell cycle progression and leukemogenesis. Leukemia 18, 189-218.
14. Szklarczyk D., Franceschini A. & Kuhn M. (2011) The STRING database in 2011: functional interaction networks of proteins, globally integrated and scored. Nucleic Acids Research 39 (Database issue): D561-D568.
15. Zainab J., Keli S., Jeffery L., M., Rajan D., Armelle M., Tanya S., Alexandra G., Saghi G., Catherine W., Ruibao R., Heather Y.R., Kenneth M. & Roya K.F. (2009) Proteasome inhibition causes regression of leukemia and abrogates BCR-ABL-induced evasion of apoptosis in part through regulation of forkhead tumor suppressors. Cancer Research 69, 6546-6555.
16. Zhu F., Wang Y., Zeng S., Fu X., Wang L. & Cao J. (2009) Involvement of Annexin A1 in Multidrug Resistance of K562/ADR Cells Identified by the Proteomic Study. OMICS: A Journal of Integrative Biology 13, 467-476.